WST Stock: Price, Earnings History and SEC Filings
West Pharmaceutical Services, Inc. (WST) last traded at $412.62, down 0.97% on the latest session and up 11.3% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $2.66 against an analyst estimate of $2.18, a beat of 22.0%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
WST earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 29, 2026 | $2.66 | $2.18 | +22.02% |
| Jun 2026 | Jul 23, 2026 | $2.37 | $2.08 | +13.94% |
| Mar 2026 | Apr 23, 2026 | $2.13 | $1.68 | +26.79% |
| Dec 2025 | Feb 12, 2026 | $2.04 | $1.83 | +11.48% |
WST beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How WST reacts to earnings
Across its last 8 earnings releases, WST moved 11.7% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-29 | Before open | +3.23% |
| 2026-07-23 | Before open | -0.82% |
| 2026-04-23 | Before open | +12.86% |
| 2026-02-12 | Before open | -1.04% |
| 2025-10-23 | Before open | +10.92% |
| 2025-07-24 | Before open | +22.78% |
| 2025-04-24 | Before open | -3.48% |
| 2025-02-13 | Before open | -38.22% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
WST financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $3.1B | $494M | $469M | 16.1% | $6.79 |
| 2024 | $2.9B | $493M | $276M | 17.0% | $6.69 |
| 2023 | $2.9B | $593M | $415M | 20.1% | $7.88 |
| 2022 | $2.9B | $586M | $439M | 20.3% | $7.73 |
| 2021 | $2.8B | $662M | $331M | 23.4% | $8.67 |
| 2020 | $2.1B | $346M | $298M | 16.1% | $4.57 |
| 2019 | $1.8B | $242M | $241M | 13.1% | $3.21 |
| 2018 | $1.7B | $207M | $184M | 12.0% | $2.74 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for WST
- 10-Q · Oct 29, 2026
- 8-K · Oct 29, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Oct 26, 2026Material agreement, Agreement terminated, New financial obligation
- 10-Q · Jul 23, 2026
- 8-K · Jul 23, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Jul 14, 2026Material agreement, Financial statements and exhibits
- 8-K · Jun 1, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · May 11, 2026Regulation FD disclosure, Financial statements and exhibits
- 8-K · May 5, 2026Shareholder vote, Financial statements and exhibits
- 10-Q · Apr 23, 2026
Insider filing activity
WST insiders filed 5 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
WST news
- How Investors Are Reacting To West (WST) Earnings BeatNov 1, 2026 · finance.yahoo.com
- West Pharmaceutical Services (WST) Lifted Its Outlook, Is The Stock Fully Priced?Nov 1, 2026 · finance.yahoo.com
- WST Q3 deep dive: Biologics and regulatory tailwinds fuel margin expansion, HVP mix shift continuesNov 1, 2026 · finance.yahoo.com
- What West Pharmaceutical Services (WST) Said on Its Q3 Earnings CallOct 31, 2026 · marketbeat.com
- West Pharmaceutical Services, Inc. Q3 2026 Earnings Call SummaryOct 29, 2026 · app.moby.co
- West (WST) Q3 2026 Earnings Call TranscriptOct 29, 2026 · fool.com
- West Pharma Q3 Earnings Rise on HVP Strength, 2026 Outlook RaisedOct 29, 2026 · finance.yahoo.com
- Compared to Estimates, West Pharmaceutical (WST) Q3 Earnings: A Look at Key MetricsOct 29, 2026 · finance.yahoo.com
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) is a US-listed public company on NYSE. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in PA. Its fiscal year ends in December.